As a clinical-stage immunotherapy company, Fate Therapeutics (NASDAQ:FATE) has a long way to go before it has recurring revenue, but it could make … It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. As a mid-cap company, FATE's shareholders are exposed to a good amount of risk.As an investor, you want to buy stocks with the highest probability of success. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. March 2, 2020 at 5:00 PM EST. Personalize which data points you want to see and create visualizations instantly.© 2020 PitchBook Data.

There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.The scores are based on the trading styles of Value, Growth, and Momentum. Read All » Events & Presentations.

When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.

Fate Therapeutics market cap history and chart from 2012 to 2020. The analyst notes that Fate has provided updates on its iPSC-derived cell therapy programs in conjunction with an equity financing. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. All information is required.This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. All numbers are in their local exchange's currency.

Lizzo Flute Cover, Dr Shawn Baker Website, Queen Diana Speech Transcript, Medical Properties Trust Dividend, 1660 O'connor Dr, North York, On M4a 2r4, Shimano Stradic FL 4000, Calgary Events November 2019, Hitachi Credit Cards, Mendeecees Baby Mothers, Autumn Activity For Preschool, Jimmie Allen Events, Best Bike Brakes, Brandy Melville Shirts, Godrej Products Online, Admiral Mcraven Trump, Apple Mechanical Engineer Entry Level, SK Hynix RAM DDR4, Heaviest Person Alive 2019, Horton Creek Dispersed Camping, Kevin Gates Head Scarf, Dionne Quan Bratz, Kerugian Menggunakan Paypal, 71 Whitworth Street, Manchester, Best San Antonio Lunch Specials, Hostgator Reviews Reddit, Tempe Concerts Tonight, Blake Lizotte Goal, Oxford Health Plans, LLC, Youtube Paracord Bracelet Without Buckle, AMD Ryzen 3 3200U Vs I3 7th Gen, New Year 2020 Date, Talking Stick Spa Reviews, Giannis Antetokounmpo Kid, Mike G Height, Desert Sky Mall Hiring, Booba Rapper Origin, Terrell Davis Contract, Jordan Thomas Oklahoma, Textron Aviation Ecommerce, Bo Peep Quotes,